[The protective effect of medroxyprogesterone acetate in patients with ovarian cancer treated with chemotherapy].
Enzelsberger
H
H
Sevelda
P
P
Salzer
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects*; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
Schutzeffekt von MPA auf die Hämatotoxizität bei Patientinnen mit Ovarialkarzinom unter Chemotherapie.